Short-Course RT Plus Chemo Can Decrease Distant Metastasis in High-Risk LARC
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
The use of total neoadjuvant therapy for locally advanced rectal cancer has increased significantly in recent years, a study suggests.
Changes in treatment have led to improvements in overall survival for US patients with rectal cancer, a study suggests.
Researchers have developed a dynamic clinical calculator that estimates conditional recurrence-free survival after total neoadjuvant therapy in patients with rectal cancer.
Overall, adjuvant chemotherapy does not appear to increase the risk of second cancers for patients with stage III-IV colon cancer.
A rectum-preserving strategy may produce outcomes similar to standard resection-based treatment for locally advanced rectal adenocarcinoma.
The 2-year actuarial rate of local recurrence was 4.8%.
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
The “watch and wait” approach is characterized by close surveillance without surgery in patients with rectal cancer who achieve a clinical CR following neoadjuvant CRT.
Get the latest treatment options for rectal cancer, including concurrent chemotherapy and radiotherapy and levoleucovorin plus 5-FU.